A recent review discussed other options besides prednisone and methotrexate in treating sarcoidosis, including antimetabolites similar in action to methotrexate, antimalarial agents, adrenocorticotropic hormone (ACTH) gel, biological agents, and antimycobacterial therapy, which is normally used to treat tuberculosis. The review, “Sarcoidosis: treatments beyond prednisone and methotrexate,” was published…
Intravenous immune globulin (IVIG) therapy, alone or combined with infliximab, may significantly ease symptoms of sarcoidosis-associated small fiber neuropathy (SSFN), according to a retrospective analysis study. The report, “Sarcoidosis-associated small fiber neuropathy in a large cohort: Clinical aspects and response to IVIG and anti-TNF alpha treatment” was published…
Measuring the levels of the blood marker soluble interleukin-2 receptor (sIL-2R) in patients with suspected sarcoidosis offers more sensitive diagnostic guidance than other commonly used markers, and allows physicians to identify patients with multiple organ involvement, according to a recent study. The marker also was seen to correspond to disease…
Closely monitoring the effect of steroid treatment in patients with cardiac sarcoidosis can help detect any resistance that may develop against the treatment and help doctors identify patients who might need increased doses of immunosuppressive therapy. Cardiac sarcoidosis, or sarcoidosis of the heart, is a medical…
A large U.S. study found that bone sarcoidosis is more prevalent in white women and is linked to a number of affected organs. According to the authors, these findings can improve the knowledge of bone involvement in sarcoidosis and the methods of detection, as well as help define treatment strategies. The…
A new study investigating the frequency and characteristics of sarcoid arthropathy, in which sarcoidosis is accompanied by joint disease, revealed that a majority of patients with sarcoidosis also have sarcoid arthritis. The study “The clinical characteristics of sarcoid arthropathy based on a prospective cohort study” was published in the…
Infliximab effectively treats neurosarcoidosis, but patients may see their disease return (relapse) over time, according to results of a new study. The study, “Long-Term Outcomes Of Refractory Neurosarcoidosis Treated With Infliximab,” was published in the Journal of Neurology. Neurosarcoidosis (sarcoidosis affecting the nervous system) may be resistant to…
While the protein osteopontin is elevated in the blood of people with sarcoidosis, the increased levels are not determined by known genetic factors, according to a recent study. Nevertheless, several DNA variants in the osteopontin gene were linked to specific disease characteristics, such as lung tissue involvement, fever, or significant weight…
MicroRNAs encased in small vesicles (exosomes) present in blood circulation may help identify sarcoidosis patients at risk of developing cardiac sarcoidosis (CS). The study “Exosomal MicroRNA for Detection of Cardiac Sarcoidosis” was published in the American Journal of Respiratory and Critical Care Medicine (AJRCCM). “CS is…
Patients with sarcoidosis have more than twice the risk of bone fractures compared to healthy people, a finding most likely linked to the inflammatory nature of the disease. While glucocorticoids — the main treatment option for sarcoidosis — are known to cause osteoporosis, researchers at the Mayo Clinic in Rochester,…
Get regular updates to your inbox.